Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk and at What Cost? Rakowski H, Bataiosu R. Circulation 2023;147:864-866.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rakowski H, Bataiosu R. Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk and at What Cost? Circulation 2023;147:864-866.
PMID: 36913498